Open Access iconOpen Access

ARTICLE

crossmark

Trametinib boosts palbociclib’s efficacy in breast cancer via autophagy inhibition

ANGUO WU1,#, JIAO YAN2,3,#, TING SU2,4, CHI FENG1, XIN LONG5,6, YIRU PAN1, RUPEI YE2, TIAN XIA2, HANAN LONG2, JIANMING WU1,*, XIULI XIAO2,*

1 Sichuan Key Medical Laboratory of New Drug Discovery and Druggability Evaluation, Luzhou Key Laboratory of Activity Screening and Druggability Evaluation for Chinese Materia Medica, Key Laboratory of Medical Electrophysiology of Ministry of Education, School of Pharmacy, Southwest Medical University, Luzhou, 646000, China
2 The Department of Pathology, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, China
3 The Department of Pathology, Mianyang Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Mianyang, 621000, China
4 The Department of Pathology, Yongchuan Hospital of Chongqing Medical University, Chongqing, 402160, China
5 School of Basic Medical Sciences, Southwest Medical University, Luzhou, 646000, China
6 School of Clinical Medical Sciences, Southwest Medical University, Luzhou, 646000, China

* Corresponding Authors: JIANMING WU. Email: email; XIULI XIAO. Email: email

TSP_OR_46139.pdf

  • 1408

    View

  • 317

    Download

  • 0

    Like

Share Link